Bioprospecting of microalgae metabolites against cytokine storm syndrome during COVID-19.
Mol Biol Rep
; 49(2): 1475-1490, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1507001
ABSTRACT
In viral respiratory infections, disrupted pathophysiological outcomes have been attributed to hyper-activated and unresolved inflammation responses of the immune system. Integration between available drugs and natural therapeutics have reported benefits in relieving inflammation-related physiological outcomes and microalgae may be a feasible source from which to draw from against future coronavirus-infections. Microalgae represent a large and diverse source of chemically functional compounds such as carotenoids and lipids that possess various bioactivities, including anti-inflammatory properties. Therefore in this paper, some implicated pathways causing inflammation in viral respiratory infections are discussed and juxtaposed along with available research done on several microalgal metabolites. Additionally, the therapeutic properties of some known anti-inflammatory, antioxidant and immunomodulating compounds sourced from microalgae are reported for added clarity.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Microalgas
/
Síndrome de Liberación de Citoquinas
/
COVID-19
/
Antiinflamatorios
/
Antioxidantes
Tópicos:
Covid persistente
Límite:
Animales
/
Humanos
Idioma:
Inglés
Revista:
Mol Biol Rep
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
S11033-021-06903-y
Similares
MEDLINE
...
LILACS
LIS